ZIVO Zivo Bioscience Inc.

Zivo Bioscience, Inc. engages in the study, development, and commercialization of natural nutritional compounds and bioactive molecules from its proprietary algal strains. The company was founded by Howard R. Baer on March 28, 1983 and is headquartered in Keego Harbor, MI.

$3.92  -0.01 (-0.25%)
As of 06/30/2022 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Consumer Staples
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  
IPO date:  10/30/2003
Outstanding shares:  9,419,660
Average volume:  22,040
Market cap:   $37,019,264
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   8.05
PS ratio:   0.00
Return on equity:   -151,671.54%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy